One of the three lots Canada’s Aurora Cannabis won in July to supply the Italian market has been canceled, Italy’s minister of health explained in a parliamentary inquiry this week, citing noncompliance with European Union Good Manufacturing Practice (GMP) standards.
In July, Alberta-based Aurora was the sole winner of the contract after all other bidders were disqualified.
The tender to supply the Italian market consisted of three different cannabis lots:
- Lot 1: 320 kilograms (705 pounds) of high-THC cannabis.
- Lot 2: 40 kilograms of similar THC and CBD content.
- Lot 3: 40 kilograms of high-CBD cannabis.
In September, however, the Ministry of the Defense decreed that the tendered Lot 3 was canceled.Aurora won all three lots, offering an average price of 1.73 euros ($1.94) per gram.
The agency cited “autotutela,” a self-protection privilege of Italian administrative law that refers to the power of the public administration to unilaterally revoke administrative acts already taken.
In the decree, the Ministry of the Defense justified the decision based on the opinion of the Stabilimento Chimico Farmaceutico di Firenze (SCFF), which considered that the supply of Lot 3, a variety with a high-CBD content, was “not necessary.”